Mast cells and their mediators have previously been linked with tumor progression and metastasis, where histamine, the primary mast cell mediator, and its receptors (HR1-HR4) were upregulated in many cancers and associated with cancer survival metastasis and recruitment of suppressive cells to the TME4. Here, CDCA7L is linked to neoplasm.